Skip to content

Trichoscopically assessing treatment outcomes of 3 treatment arms- Topical MINOXIDIL, Oral MINOXIDIL, and Topical MINOXIDIL in combination with Oral FINASTERIDE in MALE ANDROGENETIC ALOPECIA

Trichoscopic Assessment of treatment outcomes with Topical MINOXIDIL, Oral MINOXIDIL, And Topical MINOXIDIL in combination with Oral FINASTERIDE in MALE ANDROGENETIC ALOPECIA and its association with Insulin resistance - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095217
Enrollment
117
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Gunjan Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male patients above 18 years of age who have AGA and are willing to provide informed consent. 2.Patients who have not started treatment (fresh)/ or on Topical Minoxidil, Oral Minoxidil or Topical Minoxidil with Oral Finasteride for one month or less.

Exclusion criteria

Exclusion criteria: 1.Patients on any treatment for AGA for more than 1 month, before participating to the study. 2.Patients with already diagnosed systemic diseases (e.g., diabetes mellitus, malignancy, uncontrolled hypertension or hypotension, psychiatric illness, uncontrolled thyroid disorder). 3.Patients having other forms of Alopecia. 4.Patients who have undergone hair restoration surgeries previously. 5.Patients on antimetabolites.

Design outcomes

Primary

MeasureTime frame
1.To look for trichoscopic improvement in parameters (hair diameter density, single follicular units, perifollicular pigmentation, yellow dots, honeycomb pigmentation). Timepoint: baseline, 1 month, 2 months, 3 months and 4 months

Secondary

MeasureTime frame
1.Patient satisfaction grades over time Timepoint: baseline, 1 month, 2 month, 3 month & 4 month

Countries

India

Contacts

Public ContactGunjan Agarwal

Kasturba Medical College, Mangalore

agarwalgunjan0104@gmail.com9391397650

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026